10-Gingerol inhibits proliferation and invasion of MDA-MB-231 breast cancer cells through suppression of Akt and p38MAPK activity

Oncology Reports

Volumn 35, Issue 2, 2016, Pages 779-784

  Joo, Ji Hye ^a   Hong, Seong Su ^b   Cho, Young Rak ^b   Seo, Dong Wan ^a  

^a Dankook University   (South Korea)

^b Gyeonggi Biocenter   (South Korea)

Author keywords

10 gingerol; Breast cancer; Epidermal growth factor receptor

Indexed keywords

(10) GINGEROL; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; VASCULOTROPIN; ANTINEOPLASTIC AGENT; CATECHOL DERIVATIVE; FATTY ALCOHOL; GINGEROL;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL INVASION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG STRUCTURE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; BREAST TUMOR; DRUG EFFECTS; FEMALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; BREAST NEOPLASMS; CATECHOLS; CELL LINE, TUMOR; CELL PROLIFERATION; FATTY ALCOHOLS; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84954288057     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4405     Document Type: Article

References (35)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 65: 87-108, 2015.
2. Guo M, Wang M, Deng H, Zhang X and Wang ZY: A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)36 expression and inhibits growth of ER negative breast cancer MDAMB231 cells. Eur J Pharmacol 714: 56-64, 2013.
3. Munoz J, Wheler J and Kurzrock R: Expression of estrogen and progesterone receptors across human malignancies: New therapeutic opportunities. Cancer Metastasis Rev: Dec 28, 2014 (Epub ahead of print).
4. Masuda H, Zhang D, Bartholomeusz C, Doihara H, Hortobagyi GN and Ueno NT: Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res Treat 136: 331-345, 2012.
5. Dawood S, Broglio K, Buzdar AU, Hortobagyi GN and Giordano SH: Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional based review. J Clin Oncol 28: 92-98, 2010.
6. Bourboulia D and Stetler Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20: 161-168, 2010.
7. Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
8. Stetler Stevenson WG: Tissue inhibitors of metalloproteinases in cell signaling: Metalloproteinase independent biological activities. Sci Signal 1: re6, 2008.
9. Vandenbroucke RE and Libert C: Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov 13: 904-927, 2014.
10. Hadler Olsen E, Winberg JO and Uhlin Hansen L: Matrix metalloproteinases in cancer: Their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 34: 2041-2051, 2013.
11. Oyagbemi AA, Saba AB and Azeez OI: Molecular targets of [6]gingerol: Its potential roles in cancer chemoprevention. Biofactors 36: 169-178, 2010.
12. Shukla Y and Singh M: Cancer preventive properties of ginger: A brief review. Food Chem Toxicol 45: 683-690, 2007.
13. Baliga MS, Haniadka R, Pereira MM, D'Souza JJ, Pallaty PL, Bhat HP and Popuri S: Update on the chemopreventive effects of ginger and its phytochemicals. Crit Rev Food Sci Nutr 51: 499-523, 2011.
14. Lee TY, Lee KC, Chen SY and Chang HH: 6Gingerol inhibits ROS and iNOS through the suppression of PKC and NFkappaB pathways in lipopolysaccharide stimulated mouse macrophages. Biochem Biophys Res Commun 382: 134-139, 2009.
15. Lee HS, Seo EY, Kang NE and Kim WK: [6]Gingerol inhibits metastasis of MDAMB231 human breast cancer cells. J Nutr Biochem 19: 313-319, 2008.
16. Lee SH, Cekanova M and Baek SJ: Multiple mechanisms are involved in 6gingerol induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog 47: 197-208, 2008.
17. Brown AC, Shah C, Liu J, Pham JTH, Zhang JG and Jadus MR: Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro. Phytother Res 23: 640-645, 2009.
18. Weng CJ, Wu CF, Huang HW, Ho CT and Yen GC: Anti invasion effects of 6shogaol and 6gingerol, two active components in ginger, on human hepatocarcinoma cells. Mol Nutr Food Res 54: 1618-1627, 2010.
19. Kim MO, Lee MH, Oi N, Kim SH, Bae KB, Huang Z, Kim DJ, Reddy K, Lee SY, Park SJ, et al: [6] shogaol inhibits growth and induces apoptosis of non small cell lung cancer cells by directly regulating Akt1/2. Carcinogenesis 35: 683-691, 2014.
20. Fan J, Yang X and Bi Z: 6Gingerol inhibits osteosarcoma cell proliferation through apoptosis and AMPK activation. Tumour Biol 36: 1135-1141, 2015.
21. Kim JS, Lee SI, Park HW, Yang JH, Shin TY, Kim YC, Baek NI, Kim SH, Choi SU, Kwon BM, et al: Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe. Arch Pharm Res 31: 415-418, 2008.
22. Sang S, Hong J, Wu H, Liu J, Yang CS, Pan MH, Badmaev V and Ho CT: Increased growth inhibitory effects on human cancer cells and anti inflammatory potency of shogaols from Zingiber officinale relative to gingerols. J Agric Food Chem 57: 10645-10650, 2009.
23. Cho YR, Choi SW and Seo DW: The in vitro antitumor activity of Siegesbeckia glabrescens against ovarian cancer through suppression of receptor tyrosine kinase expression and the signaling pathways. Oncol Rep 30: 221-226, 2013.
24. Kim HJ, Ko HY, Choi SW and Seo DW: Anti angiogenic effects of Siegesbeckia glabrescens are mediated by suppression of the Akt and p70S6K dependent signaling pathways. Oncol Rep 33: 699-704, 2015.
25. Lee HN, Kim JK, Kim JH, Lee SJ, Ahn EK, Oh JS and Seo DW: A mechanistic study on the anti cancer activity of ethyl caffeate in human ovarian cancer SKOV3 cells. Chem Biol Interact 219: 151-158, 2014.
26. Kim SH, Cho YR, Kim HJ, Oh JS, Ahn EK, Ko HJ, Hwang BJ, Lee SJ, Cho Y, Kim YK, et al: Antagonism of VEGFAinduced increase in vascular permeability by an integrin 3-1Shp1 cAMP/PKA pathway. Blood 120: 4892-4902, 2012.
27. Kim HJ, Cho YR, Kim SH and Seo DW: TIMP2 derived 18mer peptide inhibits endothelial cell proliferation and migration through cAMP/PKA dependent mechanism. Cancer Lett 343: 210-216, 2014.
28. Lee HN, Joo JH, Oh JS, Choi SW and Seo DW: Regulatory effects of Siegesbeckia glabrescens on non small cell lung cancer cell proliferation and invasion. Am J Chin Med 42: 453-463, 2014.
29. Yoon HJ, Cho YR, Joo JH and Seo DW: Knockdown of integrin 3-1 expression induces proliferation and migration of non small cell lung cancer cells. Oncol Rep 29: 662-668, 2013.
30. Cho YR, Kim JH, Kim JK, Ahn EK, Ko HJ, In JK, Lee SJ, Bae U, Kim YK, Oh JS, et al: Broussonetia kazinoki modulates the expression of VEGFR2 and MMP2 through the inhibition of ERK, Akt and p70S6K dependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation. Oncol Rep 32: 1531-1536, 2014.
31. Jamdade VS, Sethi N, Mundhe NA, Kumar P, Lahkar M and Sinha N: Therapeutic targets of triple negative breast cancer: A review. Br J Pharmacol 172: 4228-4237, 2015.
32. Ali BH, Blunden G, Tanira MO and Nemmar A: Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem Toxicol 46: 409-420, 2008.
33. Weng CJ, Chou CP, Ho CT and Yen GC: Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6shogaol and 6gingerol. Mol Nutr Food Res 56: 1304-1314, 2012.
34. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY and Stetler Stevenson WG: TIMP2 mediated inhibition of angiogenesis: An MMP independent mechanism. Cell 114: 171-180, 2003.
35. Burness ML, Grushko TA and Olopade OI: Epidermal growth factor receptor in triple negative and basal like breast cancer: Promising clinical target or only a marker? Cancer J 16: 23-32, 2010.